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THE mixed leukocyte population obtained from
the peritoneum of the August rat is a potentially
important experimental model of inherent eos-
inophilia that has not been well characterized.
In the present study, isolated cell preparations
generated a concentration-dependent release of
leukotriene (LT) C when exposed to the Ca2+
ionophore A23187, reaching maximal stimulation
at 5.0 tM. This response was inhibited by the 5-
lipoxygenase activating protein antagonist MK-
886 (0.1 tM), nominally Ca2+ and Mg2+-free incu-
bation media and by activation of protein kinase
C via phorbol 12-myristate 13-acetate (50nM).
These findings establish a model system for
investigating LTC4 profiles contingent with innate
peritoneal eosinophilia and are consistent with
the hypothesis that cellular LTC biosynthesis is
phosphoregulated.
Key words: August rat, Eosinophilia, Leukotriene C4,
MK-886, Protein kinase C
LeukotrieneC biosynthesis in
isolated August rat peritoneal
leukocytes
J. M. Huebner,cA R. R. Eversole, W. F. Jackson,
C. D. Mackenzie,2 S. R. Stapleton and
L. J. Beuving
1Department of Biological Sciences, 5330 McCracken
Hall, Western Michigan University, Kalamazoo,
MI 49008, USA
2Department of Pathology, Michigan State
University, East Lansing, MI 48824, USA
CACorresponding Author
Tel: (616) 387 5631
Fax: (616) 387 2849
Email: huebner@wmich.edu
Introduction
The functional repertoire of both infiltrating
and in situ inflammatory cells includes the
biosynthesis and release of leukotrienes (LTs)
derived from the 5-1ipoxygenation of arachido-
nic acid (AA). Functionally, these compounds
can be divided into two classes: (1) the dihy-
droxy acid LTB4, which is a powerful chemotac-
tic, aggregative and chemokinetic agent; and
(2) the cysteinyl-containing LTs C4, D and E;
collectively termed the ’slow-reacting substance
of anaphylaxis’ or SRS-A.
2 Whereas LTB has
relatively few myotropic activities,3 the C6
amino acid-substituted cysteinyl LTs are potent
contractors of both vascular and non-vascular
smooth muscle. The relative potencies of these
compounds and their prominence in biological
fluids and inflammatory exudates suggest a role
in the pathophysiology of human bronchial
asthma and other immediate hypersensitivity
reactions.4
Under the appropriate conditions, it has now
been shown that Ca2+ mobilization can syner-
gize with protein kinase C (PKC) activation to
enhance the formation of LTs in human
eosinophils,
5 human neutrophils
6-8 and murine
macrophages.9’1 This phenomenon can be
demonstrated in vitro by the simultaneous
application of the Ca2+ ionophore A23187 and
phorbol 12-myristate 13-acetate (PMA), a tu-
mour-promoting phorbol ester which can acti-
vate PKC directly without initiating the
hydrolysis of phosphatidylinositol.
11 It has been
envisaged that the selective activities of these
agonists may mimic the cellular events respon-
sible for the release of free AA find/or the
activation of 5-1ipoxygenase (5-LO) as induced
by physiologic stimuli.7 In fact, there is evi-
dence to suggest that the phosphorylation of
specific target proteins by PKC may enhance
the A23187-stimulated release of AA in certain
cell types2’13 as well as the biosynthetic activity
of AA-selective phospholipase A2 (PEA2).14’15
In contrast, Kreiger et aL
]6 have shown that
PMA can effectively block the interleukin-3 (IL-
3)-dependent formation of LTC in human
basophils, indicating that IL-3 signalling path-
ways and LTC4 production in these cells do not
require the activation of PKC. More recently,
other laboratories have demonstrated that co-
stimulation with PMA specifically attenuates
LTC production in differentiated human pro-
myelocytic HL-60 cells challenged with iono-
phore or with saturating concentrations of
exogenous LTA4
7’18 the labile epoxide precur-
sor to both LTB and LTC.
We designed the present study to evaluate the
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capacity of August (AUG) rat mixed peritoneal Montreal, Canada). Viability cell counting was
leukocytes to generate LTC4 when challenged performed in some preparations after incubat-
with different concentrations of A23187 and to ing 100 tl of the treated cell suspension for an
test the hypothesis that LTC4 biosynthesis in additional 2 min at room temperature with a
this model is regulated via a PKC-specific mixture of ethidium bromide (0.1 pg in 100 1
phosphorylation mechanism. The AUG rat, 0.1 M phosphate buffer) and fluorescein diace-
which has a spontaneously high number of tate (2.5 Ixg in 100 t*1 0.1 M phosphate buffer,
peritoneal eosinophils
9 that can be harvested diluted from a 5 mg/ml acetone stock solution).
by a relatively simple lavage procedure,
2 is a All other reactions were terminated by the
potentially important animal model of inherent addition of 3 ml ice-cold methanol and samples
eosinophilia that has not been well studied, were stored at-70C until assayed.
Parasite-independent, non-induced examples of LTC4 content was determined by acetylcholi-
eosinophilia may prove particularly useful since nesterase (ACHE) enzyme immunoassay (EIA)
both quantitative and qualitative differences (Cayman Chemical, Ann Arbor, MI). To prepare
exist between different preparations of eosino- for analysis, samples were thawed and centri-
phils depending on the method of induction.
2 fuged at 1 500 g for 10 min at 4C to pre-
cipitate proteins. Supernatants were then
evaporated to dryness in a heated (---50C) Materials and Methods water bath under a stream of nitrogen, recon-
Except as noted, all reagents were purchased stituted in 1 ml of assay buffer and stored
from Sigma Chemical Co. (St Louis, MO). Adult overnight at 4C. Each sample was assayed in
male AUG rats (Harlan/Olac, UK) aged 27-35 duplicate according to the manufacturer’s in-
weeks were killed by CO2 inhalation and the structions. Results were interpolated from stan-
resident peritoneal cells harvested by washing dard curves fit by third or fourth-order
the cavity with 50 ml of an ice-cold CaCI2, polynomial regression (Sigma Plot software, San
MgSO4 and NaHCO-free modified Hanks’ Ba- Rafael, CA) of percentage displacement of
lanced Salt Solution (HBSS-1) buffered with bound LTC4 AChE tracer versus LTC4 concentra-
20 mM HEPES (pH 7.3). The lavage fluid was tion (pg/ml).
then aspirated by syringe and centrifuged at All data are presented as mean-+-SE. Homo-
200 g for 10 min at 4C. Pelleted cells were geneity of variance was confirmed by Hartley’s
washed, adjusted to yield 3.0 106 cells/ml test and a two-tailed, unpaired Student’s t-test
24 with HBSS-1 and differential counts then deter- was used where appropriate. A p value < 0.05
mined from cytocentrifuge slides (Cytospin 3, was considered significant.
Shandon Inc., Pittsburgh, PA) fixed and stained
with a Diff-Quik Stain Set (Baxter Scientific Results Products, McGaw Park, IL). Cell suspensions
obtained from two to three animals were Cell preparations used in all experiments con-
pooled for all experiments, tained a mixture of macrophages (45 q-1.0%),
Agonist and inhibitor stock solutions were eosinophils (36 + 0.8%), mast cells (11 +/- 0.7%)
prepared in dimethyl sulphoxide (DMSO), and lymphocytes (8 4- 0.5%) (mean 38.0 +
stored at -20C and were serially diluted 2.0 106 total cells/harvest, range 29.5
immediately before use with a HEPES-buffered 106-48.6 106, n 11). Figure 1 (inset)shows
HBSS supplemented with 2.4 mM Ca2+ and the dose-dependent stimulation of cellular LTC4
1.6 mMMg2+ at pH 7.3 (HBSS-2). The concen- biosynthesis with 0.5-10M A23187. The max-
tration of DMSO in the final reaction mixture imum measured LTC4 concentration (5.2 +
was never greater than 0.4% (v/v). To elicit 0.3 ngLTC4/IO6 cells; n= 5)was observed at
LTC4 biosynthesis, 1.5 106 cells (500 bl) were 5.0M A23187, an increase nearly 65 times
incubated with different concentrations of greater than the mean detected value observed
A23187 in 500btl of either HBSS-1 (Ca2+ and in preliminary vehicle control experiments
Mgi+-free) or HBSS-2 (final concentrations of (56.0-+-8.3 pg/lO6 cells; n 6). Removal of
1.2 mM Ca2+ and 0.8 mM Mg2+) for lOmin both CaC12 and MgSO4 from the incubation
(37C, constant agitation). In other experi- medium dramatically reduced the stimulatory
ments, cells were stimulated with 0.5 btM effects of 0.5 btM A23187, reducing elicited
A23187 in the presence of either 50 nMPMA or LTC4 levels from 577.3 + 60.9 pg/106 cells
O. 1 btM MK-886, a potent 5-1ipoxygenase activat- (n- 14) to < 30 pg/106 cells (n- 5) (not
ing protein (FLAP) inhibitor222 (generously shown). The FLAP antagonist MK-88622’23 also
provided by Dr Anthony W. Ford-Hutchinson, inhibited A23187-induced LT synthesis by over
Merck Frosst Centre for Therapeutic Research, 12-fold (p < 0.05, mean- 46.3 +/- 3.0 pg/lO6
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the concentration- and Ca2+/Mg2+-dependent
stimulation of LTC4 biosynthesis by the divalent
cation ionophore A23187 and the inhibition of
this response by MK-886,23 a specific antagonist
of FtAP activity.
22 Because MK-886 reportedly
binds FLAP at a site corresponding to its
putative AA binding domain,
25 thereby prevent-
ing the efficient transfer of AA to 5-LO, the
findings presented here thus suggest crucial
roles for Ca2+ influx and substrate availability
for the rate-limiting 5-LO enzyme.
26
Previous studies have shown that PMA and
suboptimal or threshold concentrations of
A23187 synergistically potentiate the synthesis
FIG. 1. A 5-1ipoxygenase activating protein antagonist (MK- eosinophils
5
886) and PMA-mediated activation of protein kinase C of LTC4 in human and murine
attenuate 0.5 I,M A23187-induced LTC4 biosynthesis. Data macrophages.9’1 However, consistent with find-
are expressed as mean 4-SE of at least six duplicate ings in human basophils
16 and differentiated
experiments. *p< 0.05 compared with control value, as
determined by the Student’s t-test. Inset: Dose dependence substrains of the human promyelocytic HL-60
of in vitro stimulation of LTC4 biosynthesis by A23187. Data cell line,17’18 our data suggest that PMA-mediated
are expressed as the mean of at least four duplicate activation of PKC negatively regulates cysteinyl
experiments and are shown 4-SE. LT biosynthesis. Since it can also be demon-
strated in other non-immunologic cell types that
activation of PKC does not effectively modulate
cells, n- 6) (Fig. 1, column 1 vs column 2), LTC4 release in response to A23187,
26 it thus
indicating that the fundamental integrity of the appears likely that the regulation of this biosyn-
biosynthetic pathway leading to the de novo thetic pathway may differ substantially across
formation of LTC4 was retained in our isolates, species, compartments or cell phenotypes.
Next, we investigated the possible regulatory On the other hand, this interpretation does
role of PKC in the synthesis of LTC4 by co- not fully explain the observations of other PMA-
incubating some isolates with 0.5 bM A23187 mediated effects, such as the potentiation of
and 50 nM PMA, a myristoylated phorbol ester A23187-stimulated AA release,12,13 the activation
capable of directly activating PKC in vitro. As of AA-selective PEA214’15 or the stimulation of
evidenced in Fig. 1 (column 1 vs column 3), prostanoid formation via the transcriptional
PMA reduced A23187-elicited LTC4 release by activation of the cyclooxygenase-2 gene.27’28
nearly three-fold (p < 0.05, mean- 198.8 4- In fact, PKC is known to stimulate or en-
26.1 pg/lO6 cells, n- 7), suggesting that cystei- hance prostanoid biosynthesis in several cell
nyl leukotriene production in this model may types.]7,29-34 One plausible interpretation of
be phosphoregulated. Because we found a these findings is the mechanism proposed by
slight, but significant difference in viability Ali et aL7,5 whereby the phosphorylation of
between the cells exposed to PMA (p < 0.05, LTC4 synthase, or a modulator of its activity,
mean- 83.5 4- 1.5% viable, n 5) vs isolates non-competitively inhibits LTC4 biosynthesis,
treated with ionophore alone (mean- 90.7 4- and the profile of eicosanoid mediators shifts
1.1% viable; n- 6), statistical comparisons be- from cysteinyl LTs towards the cyclooxygenase
tween the two groups were also confirmed after products of AA metabolism. The rapid accumu-
adjusting the LTC4 concentrations produced by lation of pharmacologically inactive LTA4 would
PMA-treated cells by the mean percentage not necessarily be reflected in higher levels of
difference in viability between the two treat- LTB4 production, since LTA4 hydrolase is satu-
ment groups (0.072). In this fashion, we sought rated at 40 #M.
17 If true, this hypothesis sug-
to eliminate differences that could be attribut- gests a novel negative feedback mechanism
able to cell death, whereby potent mediators such as LTD4 can
both attenuate their own production through
binding receptors that trigger the activation of
Discussion phosphatidylinositol-specific phospholipase C
and concomitantly stimulate the synthesis of
As part of a larger cooperative effort to under- other mediators (i.e. prostaglandins) some of
stand the biology of the leukocyte population which may counteract their physiological ac-
derived from the peritoneum of the syngeneic tions in tissues.17
AUG rat strain, the present study demonstrates Although it is unlikely that any one cell
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phenotype is directly responsible for all of the
clinical manifestations accompanying the patho-
genesis of inflammation,57 it should be empha-
sized that secretory responses in our mixed cell
population may not necessarily reflect the
individual responses of the different cell types.
Given the multitude of regulatory cascades that
may be actively modulated by PKC,58 as well as
the remarkably cell-specific expression of 5-LO
4 and LTC4 synthase, this complex issue requires
further careful comparative study in order to
identify the PKC protein substrates that affect
the conversion of AA into various eicosanoids
within each cellular context.
In conclusion, we now report that Ca2+
ionophore A23187-induced LTC4 synthesis by
isolated AUG rat mixed peritoneal leukocytes is
MK-886 sensitive and is both Ca2+/Mg2+ and
concentration dependent. This suggests that
these cells retain some of the functional charac-
teristics exhibited by myeloid cells derived from
other systems as well as the incipient signal
transduction cascade leading to the de novo
formation of LTC4. Furthermore, we show that
A23187-induced LTC4 production is negatively
regulated via PMA-mediated activation of PKC.
Inasmuch as LTC4 is the predominant bioactive
5-LO product of AA metabolism liberated by
human eosinophils,
59 this model system of
inherent eosinophilia could ultimately be
exploited to furnish a basis for drug develop-
ment targeted at lessening the severity of tissue
reactions associated with inflammation.
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